Epithra 100 Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Epirubicin (100mg)
Overview Epithra 100 Injection
Epithra 100 Injection treats various hematological malignancies and cancers affecting the breast, stomach, lungs, ovaries, and soft tissues. It also aids in preventing bladder cancer relapse post-surgery. Administered intravenously by a healthcare professional, it may be used alone or in conjunction with other medications as part of a combination chemotherapy regimen. Dosage and frequency are determined by your physician based on your specific condition and may vary. Strict adherence to your doctor's instructions is crucial; incorrect usage or overdosage can lead to severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinuation should only occur under medical supervision. The medication reduces contraceptive efficacy, necessitating reliable birth control for both partners throughout treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and skin rashes. It can suppress blood cell production, increasing infection risk, which can be life-threatening. Regular blood tests, along with monitoring of kidney, liver, and heart function, are essential during treatment. Prior to commencing treatment, disclose any liver or heart conditions, and provide a complete list of all medications you are currently taking, as interactions may affect Epithra 100's efficacy or mechanism. Notify your doctor if you are pregnant or breastfeeding.
Uses of Epithra 100 Injection
Malignant neoplasm
Major Benefits of Epithra 100 Injection:
Administering this medication will be done by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Epithra 100 Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Epithra 100 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Epithra 100 Injection works:
Epithra 100 Injection is a cancer therapeutic agent targeting breast cancer. Its mechanism involves inhibiting topoisomerase II, an enzyme crucial for breast cancer cell DNA replication. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage, ultimately hindering tumor growth and inducing cell death.
SAFETY ADVICE
AlcoholUNSAFE
Combining Epithra 100 Injection and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Administering Epithra 100 Injection during pregnancy is contraindicated due to established risks to the fetus. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Epithra 100 Injection while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.
DrivingUNSAFE
Administering Epithra 100 Injection might induce adverse reactions that could compromise driving capabilities. Nausea and vomiting, potential side effects of Epithra 100 Injection, may temporarily hinder safe driving.
KidneySAFE IF PRESCRIBED
Epithra 100 Injection appears safe for individuals with kidney impairment. Existing evidence indicates dose modification might be unnecessary for this population. However, physician consultation is advised. A reduced dosage could be explored for patients exhibiting serum creatinine levels exceeding 5 mg/dL.
LiverCAUTION
Patients with liver impairment should use Epithra 100 Injection cautiously, potentially requiring dosage modification. A physician's consultation is advised. Epithra 100 Injection is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Epithra 100 Injection :
NA
Facts to Know About Epithra 100 Injection
| Label | Value |
|---|---|
| Chemical Category | Anthracycline-based drug |
| Developing Good Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Cytotoxic alkaloids |
3,018 People bought this recently